Showing results (181-190 of 9,917) with videos related to

Sort By:
Pageof 992
Bone Marrow Transplantation|January 17, 2018
Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working PartyStephen P Robinson, Ariane Boumendil, Herve Finel, et al.
Bone Marrow Transplantation|January 18, 2018
Complementary therapies for fatigue after hematopoietic stem cell transplantation: an integrative reviewMohamad Baydoun, Debra L Barton
Bone Marrow Transplantation|January 26, 2018
The Japan Marrow Donor Program, 25 years of experience in achieving 20,000 bone marrow transplantations: organization structure, activity, and financial basisHidehiko Saito, Masaharu Ito, Shunichi Kato, et al.
Bone Marrow Transplantation|January 27, 2018
Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia: clinical characteristics, incidence, risk factors and outcomesNoura Alhashim, Mahmoud Aljurf, Mona Hassanein, et al.
Bone Marrow Transplantation|March 11, 2018
Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia/lymphomaYoshitaka Inoue, Shigeo Fuji, Ryuji Tanosaki, et al.
Bone Marrow Transplantation|March 11, 2018
Cost-effectiveness analysis of haploidentical vs matched unrelated allogeneic hematopoietic stem cells transplantation in patients older than 55 yearsMathias Debals-Gonthier, Carole Siani, Catherine Faucher, et al.
Bone Marrow Transplantation|March 11, 2018
Peripheral blood stem cell mobilisation with G-CSF alone versus G-CSF and cyclophosphamide after bortezomib, cyclophosphamide and dexamethasone induction in multiple myelomaChong Chyn Chua, Hui Yin Lim, Khai Li Chai, et al.
Bone Marrow Transplantation|February 1, 2018
Ocular findings and ocular graft-versus-host disease after allogeneic stem cell transplantation without total body irradiationMeeta Pathak, Phoi Phoi Diep, Xiaoran Lai, et al.
Bone Marrow Transplantation|February 3, 2018
Evaluation of infliximab as second-line treatment of acute graft versus host disease -validating response on day 7 and 28 as predictors of survivalMarietta Nygaard, Niels Smedegaard Andersen, Claus Ernst Moser, et al.
Bone Marrow Transplantation|February 21, 2018
A randomized, placebo-controlled pilot trial of aprepitant combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients undergoing cyclophosphamide-based conditioning regimens prior to hematopoietic stem cell transplant (HSCT)Joseph Bubalo, Kelsey Mulverhill, Gabrielle Meyers, et al.
Pageof 992